Ohm for me to better understand your valuation, an
Post# of 148181
-Number of common shares
-Peek MC
-Expetancy time. (e.g 5 yrs...)
-Peek Cytodyn's Revenue/yr (drug price and patients) e.g. Cancer 50000 HIV 10000 NASH 50000.
I wasn't expecting to have a valuation of more that $50B at the best. But again I'm no medical experts.